Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid Refractory Graft Versus Host Disease”

Showing 20 of 0 results

Not applicableStudy completedNCT06938165
What this trial is testing

The Safety and Efficacy of Fecal Microbiota Transplant (FMT) for Steroid-refractory Graft-versus-host Disease

Who this might be right for
GVHD
Nanfang Hospital, Southern Medical University 46
Testing effectiveness (Phase 2)Ended earlyNCT01453140
What this trial is testing

In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus

Who this might be right for
Graft Versus Host Disease
Hackensack Meridian Health 3
Testing effectiveness (Phase 2)Study completedNCT02195869
What this trial is testing

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Pharmacyclics LLC. 45
Testing effectiveness (Phase 2)Study completedNCT02824653
What this trial is testing

Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD

Who this might be right for
Graft Versus Host Disease
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 10
Testing effectiveness (Phase 2)Ended earlyNCT00038792
What this trial is testing

Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD

Who this might be right for
Acute Graft Versus Host Disease
M.D. Anderson Cancer Center 7
Large-scale testing (Phase 3)Not Yet RecruitingNCT07568535
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Remestemcel-L-rknd Added to Ruxolitinib for Grade III-IV Steroid-Refractory Acute Graft-Versus-Host Disease

Who this might be right for
GVHD - Graft-Versus-Host Disease
Mesoblast, Ltd. 180
Large-scale testing (Phase 3)Study completedNCT00179855
What this trial is testing

Extracorporeal Photopheresis for Acute Graft Versus Host Disease

Who this might be right for
Graft Versus Host DiseaseCancerStem Cell Transplantation
Ann & Robert H Lurie Children's Hospital of Chicago 10
Testing effectiveness (Phase 2)Ended earlyNCT02337517
What this trial is testing

Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
National Cancer Institute (NCI) 6
Not applicableStudy completedNCT05052385
What this trial is testing

ECP Combination Study

Who this might be right for
Steroid Refractory GVHD
European Society for Blood and Marrow Transplantation 319
Not applicableStudy completedNCT05621733
What this trial is testing

A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea

Who this might be right for
Graft-versus-Host Disease
Novartis Pharmaceuticals 140
Testing effectiveness (Phase 2)Ended earlyNCT04232397
What this trial is testing

Anlotinib Treatment in Steroid Depenent/Refractory cGVHD

Who this might be right for
Chronic Graft-versus-host-disease
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 5
Large-scale testing (Phase 3)Looking for participantsNCT06615050
What this trial is testing

Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 572
Not applicableLooking for participantsNCT06321198
What this trial is testing

A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

Who this might be right for
Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)
Anhui Provincial Hospital 12
Early research (Phase 1)Study completedNCT01672229
What this trial is testing

Bortezomib in Patients With Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Mehrdad Abedi, MD 16
Testing effectiveness (Phase 2)Ended earlyNCT02993783
What this trial is testing

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Millennium Pharmaceuticals, Inc. 17
Early research (Phase 1)Study completedNCT03158896
What this trial is testing

Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease

Who this might be right for
Acute Graft Versus Host Disease
University of Kansas Medical Center 24
Large-scale testing (Phase 3)Study completedNCT03474679
What this trial is testing

The Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Steroid Dependent/Refractory Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Graft vs Host Disease
Janssen Pharmaceutical K.K. 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT01366092
What this trial is testing

Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Who this might be right for
Chronic Graft-versus-host Disease
Dana-Farber Cancer Institute 35
Testing effectiveness (Phase 2)Looking for participantsNCT06343792
What this trial is testing

Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease

Who this might be right for
Steroid Refractory GVHD
ReAlta Life Sciences, Inc. 66
Testing effectiveness (Phase 2)WithdrawnNCT05333029
What this trial is testing

Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD

Who this might be right for
Graft Versus Host Disease
Molly Gallogly
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation